Work

Real-World Long-Term Effectiveness of Fremanezumab in Patients With Migraine Who Switched From Another mAb Targeting the CGRP Pathway – Subgroup Analysis of the FINESSE Full Analysis (P10-12.009)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211972

Authors: Andreas Straube, Gregor Broessner, Charly Gaul, Xenia Hamann, Torsten Kraya, Lars Neeb

Institutions: Ludwig-Maximilians-Universität München, Innsbruck Medical University, Teva Pharmaceuticals (Germany), Klinikum St. Georg, University Hospital in Halle, Universitätsklinikum Brandenburg an der Havel, Charité - Universitätsmedizin Berlin

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409226344

FWCI:

Cites:

Cited by:

Related to: 10